Summarized by Masters of Longevity from Startupticker.ch.
Vale Biolabs combines human brain organoids, automation and AI to predict drug responses.
Key Takeaways
- The startup is developing standardized human brain organoids.
- Predictive AI models were trained on longitudinal organoid datasets.
- Venture Kick funding has supported platform and dataset development.
